메뉴 건너뛰기
The Lancet
Volumn 377, Issue 9761, 2011, Pages 205-
Rituximab-containing therapy for chronic lymphocytic leukaemia-Authors reply
Author keywords

[No Author keywords available]
Indexed keywords

CYCLOPHOSPHAMIDE; FLUDARABINE; RITUXIMAB; ANTINEOPLASTIC AGENT; MONOCLONAL ANTIBODY;
EID: 78651436773     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(11)60042-1     Document Type: Letter
Times cited : (4)
References (3)
  • 1
    • 77957658591 scopus 로고    scopus 로고
    • Chronic lymphocytic leukaemia - Moving towards cure?
    • P Hillmen Chronic lymphocytic leukaemia - moving towards cure? Lancet 376 2010 1122 1124
    • (2010) Lancet , vol.376 , pp. 1122-1124
    • Hillmen, P.1
  • 2
    • 77957664665 scopus 로고    scopus 로고
    • Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: A randomised, open-label, phase 3 trial
    • M Hallek, K Fischer, G Fingerle-Rowson Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial Lancet 376 2010 1164 1174
    • (2010) Lancet , vol.376 , pp. 1164-1174
    • Hallek, M.1    Fischer, K.2    Fingerle-Rowson, G.3
  • 3
    • 65349111851 scopus 로고    scopus 로고
    • A challenge to the claims that fludarabine and cyclophosphamide is the new standard treatment for chronic lymphocytic leukaemia
    • I Haines, P Elliott, R Stanley A challenge to the claims that fludarabine and cyclophosphamide is the new standard treatment for chronic lymphocytic leukaemia Intern Med J 39 2009 269 271
    • (2009) Intern Med J , vol.39 , pp. 269-271
    • Haines, I.1    Elliott, P.2    Stanley, R.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.